Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Nalidixic Acid

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 65Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 ABC Farmaceutici SpA
    Italy
    		 ABC Farmaceutici S.p.A. Ivrea IT R1-CEP 2009-216 - Rev 00 Nalidixic Acid - Text Deleted 1/01/2021 2016-02-24 Withdrawn by EDQM Failure to CEP procedure Chemical 2021-01-07 701
    28/10/2024 Elixir Pharma
    India
    		 ELIXIR PHARMA Ahmedabad IN R0-CEP 2012-005 - Rev 01 Nalidixic Acid - Text Deleted 1/01/2021 2016-08-05 Expired Chemical 2018-08-03 701